Hypertrophy - 61 Studies Found
Enrolling by invitation |
: Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure : Hypertrophy, Left Ventricular : 2015-10-30 :
|
Completed |
: Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension :
: 2005-08-29 : Drug: amlodipine/benazepril |
Terminated |
: Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy :
: 2010-08-10 :
|
Completed |
: New-onset Diabetes and Left Ventricular Hypertrophy in Renal Transplantation :
|
Completed |
: Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy :
: 2011-08-18 : Drug: valsartan 80/160 mg dosage of valsartan or 160+12,5 mg valsartan+hydrochlorothiazide combination, |
Not yet recruiting |
: Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes? :
: 2016-10-07 :
|
Recruiting |
: Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography : Left Ventricular Hypertrophy : 2014-08-18 |
Recruiting |
: Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy : Hypertensive Left Ventricular Hypertrophy : 2013-04-30 :
|
Recruiting |
: Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy :
|
Completed |
: Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study :
: 2013-09-18 :
|